TD Cowen on GeneDx (WGS): '4Q First Look: 4Q & '26 Guide Match Preannouncement'
Tweet Send to a Friend
TD Cowen analyst Dan Brennan reiterated a Buy rating and $165.00 price target on GeneDx (NASDAQ: WGS).The analyst comments "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
